| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase inhibitor activity | 7.71e-07 | 8 | 49 | 3 | GO:0141039 | |
| GeneOntologyMolecularFunction | alpha-tubulin binding | 7.94e-06 | 52 | 49 | 4 | GO:0043014 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulator activity | 1.10e-05 | 18 | 49 | 3 | GO:0035014 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 7.88e-05 | 34 | 49 | 3 | GO:0050750 | |
| GeneOntologyMolecularFunction | gamma-tubulin binding | 1.10e-04 | 38 | 49 | 3 | GO:0043015 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 1.19e-04 | 39 | 49 | 3 | GO:0070325 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 1.64e-04 | 8 | 49 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 4.10e-04 | 59 | 49 | 3 | GO:0001222 | |
| GeneOntologyMolecularFunction | tubulin binding | 6.00e-04 | 428 | 49 | 6 | GO:0015631 | |
| GeneOntologyMolecularFunction | kinase regulator activity | 8.85e-04 | 305 | 49 | 5 | GO:0019207 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.28e-03 | 753 | 49 | 7 | GO:0008134 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol import | 2.21e-07 | 6 | 47 | 3 | GO:1904109 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol import | 9.23e-07 | 9 | 47 | 3 | GO:0060620 | |
| GeneOntologyBiologicalProcess | polar body extrusion after meiotic divisions | 1.32e-06 | 10 | 47 | 3 | GO:0040038 | |
| GeneOntologyBiologicalProcess | meiotic cytokinesis | 3.12e-06 | 13 | 47 | 3 | GO:0033206 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization to nucleolus | 5.08e-06 | 2 | 47 | 2 | GO:1904750 | |
| GeneOntologyBiologicalProcess | cholesterol import | 6.08e-06 | 16 | 47 | 3 | GO:0070508 | |
| GeneOntologyBiologicalProcess | dendritic cell antigen processing and presentation | 1.43e-05 | 21 | 47 | 3 | GO:0002468 | |
| GeneOntologyBiologicalProcess | presynapse to nucleus signaling pathway | 1.52e-05 | 3 | 47 | 2 | GO:0099526 | |
| GeneOntologyBiologicalProcess | endosome to plasma membrane protein transport | 2.17e-05 | 24 | 47 | 3 | GO:0099638 | |
| GeneOntologyBiologicalProcess | presynaptic signal transduction | 3.04e-05 | 4 | 47 | 2 | GO:0098928 | |
| GeneOntologyBiologicalProcess | meiotic spindle assembly | 3.49e-05 | 28 | 47 | 3 | GO:0090306 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol transport | 3.81e-05 | 83 | 47 | 4 | GO:0032374 | |
| GeneOntologyBiologicalProcess | regulation of sterol transport | 3.81e-05 | 83 | 47 | 4 | GO:0032371 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to cell surface | 3.89e-05 | 29 | 47 | 3 | GO:2000010 | |
| GeneOntologyBiologicalProcess | regulation of Arp2/3 complex-mediated actin nucleation | 4.77e-05 | 31 | 47 | 3 | GO:0034315 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 5.06e-05 | 5 | 47 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | regulation of lipid transport | 5.31e-05 | 179 | 47 | 5 | GO:0032368 | |
| GeneOntologyBiologicalProcess | maintenance of presynaptic active zone structure | 7.58e-05 | 6 | 47 | 2 | GO:0048790 | |
| GeneOntologyBiologicalProcess | meiotic spindle organization | 8.16e-05 | 37 | 47 | 3 | GO:0000212 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 8.85e-05 | 38 | 47 | 3 | GO:0007026 | |
| GeneOntologyBiologicalProcess | regulation of plasma lipoprotein particle levels | 8.87e-05 | 103 | 47 | 4 | GO:0097006 | |
| GeneOntologyBiologicalProcess | positive regulation of sterol transport | 1.03e-04 | 40 | 47 | 3 | GO:0032373 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol transport | 1.03e-04 | 40 | 47 | 3 | GO:0032376 | |
| GeneOntologyBiologicalProcess | regulation of actin nucleation | 1.11e-04 | 41 | 47 | 3 | GO:0051125 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein particle clearance | 1.11e-04 | 41 | 47 | 3 | GO:0034383 | |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 1.20e-04 | 42 | 47 | 3 | GO:0031114 | |
| GeneOntologyBiologicalProcess | regulation of lipid localization | 1.26e-04 | 215 | 47 | 5 | GO:1905952 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 1.68e-04 | 47 | 47 | 3 | GO:0001556 | |
| GeneOntologyBiologicalProcess | Arp2/3 complex-mediated actin nucleation | 1.68e-04 | 47 | 47 | 3 | GO:0034314 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent cytokinesis | 1.99e-04 | 127 | 47 | 4 | GO:0061640 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule polymerization or depolymerization | 2.14e-04 | 51 | 47 | 3 | GO:0031111 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell surface | 2.14e-04 | 51 | 47 | 3 | GO:2000008 | |
| GeneOntologyBiologicalProcess | presynaptic active zone organization | 2.26e-04 | 10 | 47 | 2 | GO:1990709 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 2.27e-04 | 52 | 47 | 3 | GO:0007143 | |
| GeneOntologyBiologicalProcess | cholesterol transport | 2.45e-04 | 134 | 47 | 4 | GO:0030301 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to nucleolus | 2.76e-04 | 11 | 47 | 2 | GO:1904749 | |
| GeneOntologyBiologicalProcess | sterol transport | 2.81e-04 | 139 | 47 | 4 | GO:0015918 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 2.81e-04 | 139 | 47 | 4 | GO:0019882 | |
| GeneOntologyBiologicalProcess | presynapse assembly | 3.46e-04 | 60 | 47 | 3 | GO:0099054 | |
| GeneOntologyBiologicalProcess | regulation of cytokine production | 3.96e-04 | 1010 | 47 | 9 | GO:0001817 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle clearance | 4.00e-04 | 63 | 47 | 3 | GO:0034381 | |
| GeneOntologyBiologicalProcess | actin nucleation | 4.39e-04 | 65 | 47 | 3 | GO:0045010 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | 4.55e-04 | 438 | 47 | 6 | GO:1902903 | |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 4.59e-04 | 66 | 47 | 3 | GO:0007019 | |
| GeneOntologyBiologicalProcess | presynapse organization | 6.17e-04 | 73 | 47 | 3 | GO:0099172 | |
| GeneOntologyBiologicalProcess | cytokine production | 6.93e-04 | 1091 | 47 | 9 | GO:0001816 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to plasma membrane | 6.94e-04 | 76 | 47 | 3 | GO:0061951 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | CACNA1B WASH6P WASH3P OSM TBC1D4 CEP295NL WASHC1 NAV3 TAOK1 CKAP2 | 7.43e-04 | 1342 | 47 | 10 | GO:0033043 |
| GeneOntologyBiologicalProcess | protein localization to cell surface | 7.77e-04 | 79 | 47 | 3 | GO:0034394 | |
| GeneOntologyBiologicalProcess | protein localization to nucleolus | 8.48e-04 | 19 | 47 | 2 | GO:1902570 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 8.99e-04 | 330 | 47 | 5 | GO:0040029 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 9.74e-04 | 1390 | 47 | 10 | GO:0045944 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 1.10e-03 | 89 | 47 | 3 | GO:1901880 | |
| GeneOntologyBiologicalProcess | synaptic vesicle clustering | 1.14e-03 | 22 | 47 | 2 | GO:0097091 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | 1.14e-03 | 720 | 47 | 7 | GO:0000226 | |
| GeneOntologyBiologicalProcess | cytokinesis | 1.19e-03 | 204 | 47 | 4 | GO:0000910 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 1.31e-03 | 957 | 47 | 8 | GO:0097435 | |
| GeneOntologyBiologicalProcess | endocytic recycling | 1.33e-03 | 95 | 47 | 3 | GO:0032456 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 1.36e-03 | 24 | 47 | 2 | GO:0071625 | |
| GeneOntologyBiologicalProcess | oocyte development | 1.49e-03 | 99 | 47 | 3 | GO:0048599 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 1.54e-03 | 100 | 47 | 3 | GO:0043242 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid transport | 1.63e-03 | 102 | 47 | 3 | GO:0032370 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | CDKN2A HDAC9 ATXN2 SIGIRR FURIN MBD1 NAV3 RELB BRINP1 EIF2AK3 | 1.63e-03 | 1488 | 47 | 10 | GO:0051241 |
| GeneOntologyBiologicalProcess | oocyte differentiation | 1.67e-03 | 103 | 47 | 3 | GO:0009994 | |
| GeneOntologyBiologicalProcess | regulation of protein ubiquitination | 1.73e-03 | 226 | 47 | 4 | GO:0031396 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 1.77e-03 | 105 | 47 | 3 | GO:1901879 | |
| GeneOntologyBiologicalProcess | endosome organization | 1.82e-03 | 106 | 47 | 3 | GO:0007032 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 1.87e-03 | 231 | 47 | 4 | GO:0032271 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 1.91e-03 | 108 | 47 | 3 | GO:0031110 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | 1.93e-03 | 579 | 47 | 6 | GO:0051493 | |
| GeneOntologyBiologicalProcess | retrograde transport, endosome to Golgi | 1.97e-03 | 109 | 47 | 3 | GO:0042147 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagy | 2.12e-03 | 112 | 47 | 3 | GO:0010507 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 2.15e-03 | 240 | 47 | 4 | GO:0140013 | |
| GeneOntologyBiologicalProcess | vesicle organization | 2.47e-03 | 415 | 47 | 5 | GO:0016050 | |
| GeneOntologyBiologicalProcess | microtubule-based process | 2.47e-03 | 1058 | 47 | 8 | GO:0007017 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 2.54e-03 | 418 | 47 | 5 | GO:0009895 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | 2.62e-03 | 421 | 47 | 5 | GO:0010639 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | 2.65e-03 | 617 | 47 | 6 | GO:0022411 | |
| GeneOntologyBiologicalProcess | meiotic chromosome segregation | 2.71e-03 | 122 | 47 | 3 | GO:0045132 | |
| GeneOntologyBiologicalProcess | peptide biosynthetic process | 2.72e-03 | 34 | 47 | 2 | GO:0043043 | |
| GeneOntologyBiologicalProcess | regulation of vesicle fusion | 2.88e-03 | 35 | 47 | 2 | GO:0031338 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 2.97e-03 | 126 | 47 | 3 | GO:0033555 | |
| GeneOntologyBiologicalProcess | exocytosis | 2.99e-03 | 434 | 47 | 5 | GO:0006887 | |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | 3.04e-03 | 264 | 47 | 4 | GO:0099504 | |
| GeneOntologyCellularComponent | WASH complex | 5.40e-06 | 15 | 49 | 3 | GO:0071203 | |
| GeneOntologyCellularComponent | BLOC-1 complex | 9.63e-06 | 18 | 49 | 3 | GO:0031083 | |
| GeneOntologyCellularComponent | exocyst | 1.56e-05 | 21 | 49 | 3 | GO:0000145 | |
| GeneOntologyCellularComponent | BLOC complex | 2.07e-05 | 23 | 49 | 3 | GO:0031082 | |
| GeneOntologyCellularComponent | inhibitory synapse | 5.19e-05 | 31 | 49 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 1.49e-04 | 8 | 49 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 4.81e-04 | 14 | 49 | 2 | GO:0099569 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 5.88e-04 | 164 | 49 | 4 | GO:0098982 | |
| GeneOntologyCellularComponent | vesicle tethering complex | 6.44e-04 | 72 | 49 | 3 | GO:0099023 | |
| GeneOntologyCellularComponent | centriole | 7.03e-04 | 172 | 49 | 4 | GO:0005814 | |
| GeneOntologyCellularComponent | trans-Golgi network | 7.32e-04 | 306 | 49 | 5 | GO:0005802 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.32e-03 | 23 | 49 | 2 | GO:0098831 | |
| GeneOntologyCellularComponent | cell cortex | 1.72e-03 | 371 | 49 | 5 | GO:0005938 | |
| GeneOntologyCellularComponent | excitatory synapse | 2.02e-03 | 107 | 49 | 3 | GO:0060076 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.31e-03 | 112 | 49 | 3 | GO:0055038 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 2.42e-03 | 114 | 49 | 3 | GO:0005798 | |
| GeneOntologyCellularComponent | ribbon synapse | 2.55e-03 | 32 | 49 | 2 | GO:0097470 | |
| GeneOntologyCellularComponent | autophagosome | 2.74e-03 | 119 | 49 | 3 | GO:0005776 | |
| GeneOntologyCellularComponent | filopodium | 3.01e-03 | 123 | 49 | 3 | GO:0030175 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 3.70e-03 | 443 | 49 | 5 | GO:0098791 | |
| GeneOntologyCellularComponent | presynaptic active zone | 4.41e-03 | 141 | 49 | 3 | GO:0048786 | |
| GeneOntologyCellularComponent | cell cortex region | 5.00e-03 | 45 | 49 | 2 | GO:0099738 | |
| GeneOntologyCellularComponent | microtubule organizing center | 5.32e-03 | 919 | 49 | 7 | GO:0005815 | |
| MousePheno | abnormal ectoplacental cavity morphology | 7.60e-06 | 15 | 37 | 3 | MP:0011202 | |
| MousePheno | abnormal extraembryonic coelom morphology | 1.89e-05 | 20 | 37 | 3 | MP:0011200 | |
| MousePheno | abnormal amniotic cavity morphology | 3.77e-05 | 25 | 37 | 3 | MP:0011199 | |
| Domain | Znf_piccolo | 5.42e-06 | 2 | 44 | 2 | IPR008899 | |
| Domain | zf-piccolo | 5.42e-06 | 2 | 44 | 2 | PF05715 | |
| Domain | WH2 | 1.45e-03 | 24 | 44 | 2 | PS51082 | |
| Domain | IPT | 1.83e-03 | 27 | 44 | 2 | SM00429 | |
| Domain | TIG | 2.42e-03 | 31 | 44 | 2 | PF01833 | |
| Domain | IPT | 2.57e-03 | 32 | 44 | 2 | IPR002909 | |
| Domain | Znf_FYVE_PHD | 5.00e-03 | 147 | 44 | 3 | IPR011011 | |
| Domain | zf-C2H2 | 5.42e-03 | 693 | 44 | 6 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 5.46e-03 | 694 | 44 | 6 | IPR013087 | |
| Domain | ZINC_FINGER_C2H2_2 | 9.21e-03 | 775 | 44 | 6 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 9.32e-03 | 777 | 44 | 6 | PS00028 | |
| Domain | Znf_C2H2-like | 1.04e-02 | 796 | 44 | 6 | IPR015880 | |
| Domain | Znf_C2H2 | 1.10e-02 | 805 | 44 | 6 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.12e-02 | 808 | 44 | 6 | SM00355 | |
| Domain | 4_helix_cytokine-like_core | 1.32e-02 | 74 | 44 | 2 | IPR009079 | |
| Pubmed | Characterization of the murine orthologue of a novel human subtelomeric multigene family. | 2.40e-11 | 5 | 53 | 4 | 11701968 | |
| Pubmed | Human subtelomeric WASH genes encode a new subclass of the WASP family. | 7.19e-11 | 6 | 53 | 4 | 18159949 | |
| Pubmed | Differentially regulated and evolved genes in the fully sequenced Xq/Yq pseudoautosomal region. | 3.35e-10 | 8 | 53 | 4 | 10655549 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 38086439 | ||
| Pubmed | WASH Regulates Glucose Homeostasis by Facilitating Glut2 Receptor Recycling in Pancreatic β-Cells. | 3.34e-09 | 3 | 53 | 3 | 30425062 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 25225459 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 23275443 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 32492429 | ||
| Pubmed | The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance. | 1.34e-08 | 4 | 53 | 3 | 31167970 | |
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 32879135 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 22718907 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 24886983 | ||
| Pubmed | Endosomal WASH and exocyst complexes control exocytosis of MT1-MMP at invadopodia. | 3.33e-08 | 5 | 53 | 3 | 24344185 | |
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 20308062 | ||
| Pubmed | Diverse fates of paralogs following segmental duplication of telomeric genes. | 3.44e-08 | 22 | 53 | 4 | 15233989 | |
| Pubmed | WASH complex regulates Arp2/3 complex for actin-based polar body extrusion in mouse oocytes. | 6.66e-08 | 6 | 53 | 3 | 24998208 | |
| Pubmed | WASH maintains NKp46+ ILC3 cells by promoting AHR expression. | 1.16e-07 | 7 | 53 | 3 | 28589939 | |
| Pubmed | 1.86e-07 | 8 | 53 | 3 | 27927957 | ||
| Pubmed | A FAM21-containing WASH complex regulates retromer-dependent sorting. | 1.86e-07 | 8 | 53 | 3 | 19922874 | |
| Pubmed | RNF2 is recruited by WASH to ubiquitinate AMBRA1 leading to downregulation of autophagy. | 2.79e-07 | 9 | 53 | 3 | 24980959 | |
| Pubmed | Regulation of WASH-dependent actin polymerization and protein trafficking by ubiquitination. | 3.98e-07 | 10 | 53 | 3 | 23452853 | |
| Pubmed | WASH inhibits autophagy through suppression of Beclin 1 ubiquitination. | 3.98e-07 | 10 | 53 | 3 | 23974797 | |
| Pubmed | 5.47e-07 | 11 | 53 | 3 | 26965651 | ||
| Pubmed | The Arp2/3 activator WASH controls the fission of endosomes through a large multiprotein complex. | 7.28e-07 | 12 | 53 | 3 | 19922875 | |
| Pubmed | 7.28e-07 | 12 | 53 | 3 | 27390154 | ||
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 21228161 | ||
| Pubmed | Parkin mediates the ubiquitination of VPS35 and modulates retromer-dependent endosomal sorting. | 1.50e-06 | 15 | 53 | 3 | 29893854 | |
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 2.28e-06 | 2 | 53 | 2 | 23403927 | |
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 2.28e-06 | 2 | 53 | 2 | 26793095 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 11285225 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 20332206 | ||
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 2.28e-06 | 2 | 53 | 2 | 21935939 | |
| Pubmed | WASH and the Arp2/3 complex regulate endosome shape and trafficking. | 2.28e-06 | 2 | 53 | 2 | 20175130 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 27321892 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 32493491 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 24488495 | ||
| Pubmed | Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo. | 2.28e-06 | 2 | 53 | 2 | 25652077 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 21671477 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 27791392 | ||
| Pubmed | Bisphenol A Induces Accelerated Cell Aging in Murine Endothelium. | 6.83e-06 | 3 | 53 | 2 | 34680063 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 7.60e-06 | 475 | 53 | 7 | 31040226 | |
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 23267082 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 18549475 | ||
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 19812333 | ||
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 14734538 | ||
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 19666599 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 4.37e-05 | 857 | 53 | 8 | 25609649 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 5.14e-05 | 877 | 53 | 8 | 20211142 | |
| Pubmed | New common variants affecting susceptibility to basal cell carcinoma. | 6.34e-05 | 8 | 53 | 2 | 19578363 | |
| Pubmed | 6.61e-05 | 51 | 53 | 3 | 16919471 | ||
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 21144999 | ||
| Pubmed | Regulation of NF-κB by the p105-ABIN2-TPL2 complex and RelAp43 during rabies virus infection. | 1.02e-04 | 10 | 53 | 2 | 29084252 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.22e-04 | 736 | 53 | 7 | 29676528 | |
| Pubmed | Multiple roles of integrin-α3 at the neuromuscular junction. | 1.49e-04 | 12 | 53 | 2 | 28386022 | |
| Pubmed | Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma. | 2.05e-04 | 14 | 53 | 2 | 24403052 | |
| Pubmed | 2.05e-04 | 14 | 53 | 2 | 16452088 | ||
| Pubmed | 2.36e-04 | 15 | 53 | 2 | 31903119 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | 2.83e-04 | 1124 | 53 | 8 | 21900206 | |
| Pubmed | 4.03e-04 | 227 | 53 | 4 | 26410627 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 4.97e-04 | 430 | 53 | 5 | 35044719 | |
| Pubmed | 5.16e-04 | 22 | 53 | 2 | 25331947 | ||
| Pubmed | 5.61e-04 | 105 | 53 | 3 | 9628581 | ||
| Pubmed | 9.44e-04 | 496 | 53 | 5 | 31343991 | ||
| Pubmed | Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. | 1.03e-03 | 31 | 53 | 2 | 14684825 | |
| Pubmed | 1.03e-03 | 31 | 53 | 2 | 15217342 | ||
| Pubmed | 1.04e-03 | 130 | 53 | 3 | 12421765 | ||
| Pubmed | Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. | 1.24e-03 | 34 | 53 | 2 | 20581827 | |
| Pubmed | 1.24e-03 | 34 | 53 | 2 | 24026423 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.38e-03 | 1105 | 53 | 7 | 35748872 | |
| Pubmed | 1.46e-03 | 1116 | 53 | 7 | 31753913 | ||
| Cytoband | 9p24.3 | 1.18e-04 | 14 | 53 | 2 | 9p24.3 | |
| Cytoband | Xp22.33 | 3.86e-04 | 25 | 53 | 2 | Xp22.33 | |
| Cytoband | 7p22.3 | 7.16e-04 | 34 | 53 | 2 | 7p22.3 | |
| Cytoband | 22q12.2 | 2.07e-03 | 58 | 53 | 2 | 22q12.2 | |
| Cytoband | 7q36.1 | 3.35e-03 | 74 | 53 | 2 | 7q36.1 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 1.65e-08 | 16 | 33 | 4 | 14 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.34e-04 | 15 | 33 | 2 | 26 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 8.70e-04 | 24 | 33 | 2 | 654 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.70e-03 | 718 | 33 | 6 | 28 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.97e-08 | 177 | 52 | 6 | a0ff337f11bdb11959ac71805ff94be6b4ec1083 | |
| ToppCell | (3)_MNP-(3)_DC_activated|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.36e-08 | 191 | 52 | 6 | 0353bf797c4ef237b9bb82460c173c7d03cb8883 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.88e-06 | 175 | 52 | 5 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.16e-06 | 180 | 52 | 5 | 32d871738a24071b70084a7e80148a516110c78b | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.16e-06 | 180 | 52 | 5 | 067ca8a15228c7f3b3bc7aecbc9b1611ca05e176 | |
| ToppCell | (3)_DC_activated|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.75e-06 | 189 | 52 | 5 | e977838793fc0eb1499e81018e33e4ccb4a5f0c5 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.97e-06 | 192 | 52 | 5 | e44e37e5aeba8628556020d05e1606b28e2faa4f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-05 | 152 | 52 | 4 | 0fda8980b10ce16179dea92301db74d728f41794 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.31e-05 | 167 | 52 | 4 | 43a9375fdbafd7450c553e4620e21537e08639dd | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.42e-05 | 168 | 52 | 4 | 63437b3c3a66f953eaed600965ab193f9cc49da2 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.52e-05 | 169 | 52 | 4 | 44d201361eb497222a4972a0e10bac1e05dcfd0a | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 4.62e-05 | 170 | 52 | 4 | 9e328e1f904c77dcce8aee4df775d7f0ac725775 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.95e-05 | 173 | 52 | 4 | 94f99f7e7813d6e53e0bedf97087400b1bf00129 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-05 | 174 | 52 | 4 | e9e4532a474b4b0938a50ff85c9508aca53cd3ae | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 176 | 52 | 4 | 24b2e94ee5defcefb64a1f2447a2cc71b015b0fd | |
| ToppCell | systemic_lupus_erythematosus-managed|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.29e-05 | 176 | 52 | 4 | e406a05345461d23cba21c5444223c937143e96a | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.29e-05 | 176 | 52 | 4 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.41e-05 | 177 | 52 | 4 | f360f7099570d248531897b96e0de282e58f59e9 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-aDC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.41e-05 | 177 | 52 | 4 | ccf5dc54780d6039a4d062dee88440c011ddc0a3 | |
| ToppCell | BAL-Mild-Myeloid-Neutrophil-Neutrophil-Neu_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.51e-05 | 63 | 52 | 3 | 1c8f4d173a6348cf5ea3d7d099b48dabc15d07ac | |
| ToppCell | BAL-Mild-Myeloid-Neutrophil-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.51e-05 | 63 | 52 | 3 | 9c108339b9d03a5f88de61c25e4ba920138245cc | |
| ToppCell | Mild_COVID-19-Myeloid-Neutrophil|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 5.51e-05 | 63 | 52 | 3 | de62e0692cda074dffb036c2d276ac33656c8a43 | |
| ToppCell | BAL-Mild-Myeloid-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.51e-05 | 63 | 52 | 3 | 8874c58f3996f98323ca894647a25569727e3652 | |
| ToppCell | BAL-Mild-Myeloid-Neutrophil-Neutrophil-Neu_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.51e-05 | 63 | 52 | 3 | 63471d9ae567d3275561729048a4cb78407d28f6 | |
| ToppCell | BAL-Mild-Myeloid-Neutrophil-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.51e-05 | 63 | 52 | 3 | 13aa61e3d54d7290df7ef982c70b2b4e9f6c7a32 | |
| ToppCell | BAL-Mild-Myeloid-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.51e-05 | 63 | 52 | 3 | bc8a5e40d828110c650a4760eaf682dbfacd8b5b | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.56e-05 | 186 | 52 | 4 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | PBMC-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters | 6.69e-05 | 187 | 52 | 4 | 0afef5baf3752314dbfb024790347d5e51f9b84b | |
| ToppCell | Mild-Myeloid-mDC-|Mild / Condition, Lineage, Cell class and cell subclass | 7.41e-05 | 192 | 52 | 4 | 8520b3fdf4508ac66f7918da613abc928ab5832a | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.41e-05 | 192 | 52 | 4 | dfb9101622f7d2f2c392e850cff07becfc8c655e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.41e-05 | 192 | 52 | 4 | d39133cf1a20af6f2970188630fc3b27a4cfc9c5 | |
| ToppCell | Mild-Myeloid-mDC|Mild / Condition, Lineage, Cell class and cell subclass | 7.41e-05 | 192 | 52 | 4 | da3952bd5c96242c15eb76678d0608ae2926a16e | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.56e-05 | 193 | 52 | 4 | a2194012dfa0174c6160900625c44e0fd04c50e7 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.56e-05 | 193 | 52 | 4 | 7426a30ed01e5c8376b3e0ebe0f1057cfee88340 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Activated_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 7.72e-05 | 194 | 52 | 4 | 219056d4ad256cda73208b8c570bbf689219df83 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 7.72e-05 | 194 | 52 | 4 | 30f683725cb13ae32ef6846618801ec78e12397d | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.72e-05 | 194 | 52 | 4 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.87e-05 | 195 | 52 | 4 | ecf7d9856a5b507ec17c325c9a772dc5a184bc8e | |
| ToppCell | COVID-19_Severe-cDC|COVID-19_Severe / disease group, cell group and cell class | 7.87e-05 | 195 | 52 | 4 | 6419090b19de7b5d5140eaecf231860273da2c0d | |
| ToppCell | COVID-19_Severe-cDC|World / disease group, cell group and cell class | 8.35e-05 | 198 | 52 | 4 | c452334249f047265ae89dcabe7de446d968cae6 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.33e-04 | 144 | 52 | 3 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.33e-04 | 144 | 52 | 3 | bdd6d00b2d1c9dad989df82367a60e8be79de816 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.12e-04 | 150 | 52 | 3 | b6f1fc62d08199fed6156c7cd32f66d9926531b5 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-maDC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.54e-04 | 153 | 52 | 3 | b03375c54aa701817c0fc2c3fef32b870169e697 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.54e-04 | 153 | 52 | 3 | 18bd770a18e642581a6df144d47184c1ac383713 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.69e-04 | 154 | 52 | 3 | b16f3139ce50e70a6a2377b1da7d7877b4000ea1 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.13e-04 | 157 | 52 | 3 | 8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.13e-04 | 157 | 52 | 3 | ee1be3c756b72fceac6b4ccb416dd4bd031a2193 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.13e-04 | 157 | 52 | 3 | 008f938a338f43c3251dcac574f1b4f689926c71 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.13e-04 | 157 | 52 | 3 | 6730b775308f45a2f3946016bdbb7f8e5b5efe49 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Mast|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.58e-04 | 160 | 52 | 3 | 6393e3d5c5c8176c93aecd89b313bd054a00d474 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.58e-04 | 160 | 52 | 3 | 01f22cdb2a2f73776b7f91746e95c1850df94235 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.58e-04 | 160 | 52 | 3 | 2065938e944eb99478fd8132c2c03adeaee6d447 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-maDC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.58e-04 | 160 | 52 | 3 | 7db30647b596f0c419087e6fabb9b99dcd5bddd4 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.74e-04 | 161 | 52 | 3 | 0dd1401b4c990d49fccb702a9f9867590a58e203 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-04 | 161 | 52 | 3 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.74e-04 | 161 | 52 | 3 | b6a31c033edc74f23a20aab1f18e80cc83ffee4c | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.74e-04 | 161 | 52 | 3 | efb811dda4d73107983a5f68302bdcf4f408d5b4 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.74e-04 | 161 | 52 | 3 | 78cc5bc488bc47726195a649946d414e6bfabf94 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.74e-04 | 161 | 52 | 3 | 28d5dbd20c9f8e0069f172d552997a044790e1a7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-04 | 161 | 52 | 3 | 4f25eeabb841b0b9204cdd4e71d5e131e7868184 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.90e-04 | 162 | 52 | 3 | 0fa93efc9c005d1e649b3f7069ae8641d6e41ed8 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-04 | 163 | 52 | 3 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.06e-04 | 163 | 52 | 3 | bca9abd02ffb2a90c8386a59f5e25126ae7b6acd | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.06e-04 | 163 | 52 | 3 | a09449a502627aa369db600dba5bda93de7ce5c0 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-04 | 163 | 52 | 3 | abec4389cd88252449f110fe95416d67424b403a | |
| ToppCell | COVID-mono3|COVID / Condition, Cell_class and T cell subcluster | 9.06e-04 | 163 | 52 | 3 | 6ab4cbcd411b40920b81162c0f4b03ea67408f52 | |
| ToppCell | COVID-mono3-|COVID / Condition, Cell_class and T cell subcluster | 9.06e-04 | 163 | 52 | 3 | 26661c7a3a0a449ed32d4b3b28fc2fc0b237025d | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-04 | 163 | 52 | 3 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | Int-URO-Myeloid-cDC1|Int-URO / Disease, Lineage and Cell Type | 9.22e-04 | 164 | 52 | 3 | f4628a7ff0dc765a5337ab499b3d61fc25573a16 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Basophil|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.22e-04 | 164 | 52 | 3 | dc22b1fef49c1557a0b63c536eaba574dfcab715 | |
| ToppCell | Mild-MAIT|World / Disease group and Cell class | 9.22e-04 | 164 | 52 | 3 | 21dc02997dfae73cf70ce291661928526605dba1 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.22e-04 | 164 | 52 | 3 | ed888b55d9c685096fd785878fcb264f4fee88d6 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.22e-04 | 164 | 52 | 3 | f4de9f18134a06f3d7fcf5b50b8e21c1506e2083 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-04 | 166 | 52 | 3 | c22b0f3bf990d94b615a3aacee5de548da2db628 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-04 | 166 | 52 | 3 | 0975fc165bcc7e85f053d9d0244fffe407c23571 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-MAIT|ICU-NoSEP / Disease, Lineage and Cell Type | 9.55e-04 | 166 | 52 | 3 | d3fa2e42497201f1ca57f4f977fbaa0def950033 | |
| ToppCell | Dividing_Macrophages-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 9.55e-04 | 166 | 52 | 3 | ea95b94ccc2ac67df741b30c27f4ae698925875f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Th1|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.71e-04 | 167 | 52 | 3 | 9c55ec8f70b86d4d3d5c2a6ecd9bff2dafe68c11 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.88e-04 | 168 | 52 | 3 | 0e99ecd94ab8e5372e30433d7d0aa76b4d54257a | |
| ToppCell | BAL-Severe-cDC_5|Severe / Compartment, Disease Groups and Clusters | 9.88e-04 | 168 | 52 | 3 | 857a80c217a5513553460798a625612031bc7bb7 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.88e-04 | 168 | 52 | 3 | 34722e14f28313f2e4644b3c1861ef12958cee9f | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-03 | 169 | 52 | 3 | f2e20049a17eee533d49bd5f24a51962d123d132 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-03 | 169 | 52 | 3 | 4c6892551e9dec94fc62b3beab1e6d424639a1e9 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-03 | 169 | 52 | 3 | da607c1d068038d5a3d1117f6aa6e4c6f3552e97 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-03 | 169 | 52 | 3 | a14b46231e079a0fd9f3ca13d5d48113be76fd0f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-03 | 170 | 52 | 3 | 21bfe070e63722672176052b386167ea4c3dc4e5 | |
| ToppCell | (7)_MNP-(7)_DC_activated|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.02e-03 | 170 | 52 | 3 | 4ab495b38a071fa8207331df2ce0d78a2dcd034e | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-03 | 170 | 52 | 3 | df1a34a69ae404c56f00751a01f52359535f5469 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-03 | 170 | 52 | 3 | 513d9036aa41d4d902da8baa66a66206abb6f3b0 | |
| ToppCell | Mild-Treg|World / Disease group and Cell class | 1.02e-03 | 170 | 52 | 3 | f3f177534badca34e1ae8671b7f583ee6688e14b | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_mature_DC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.04e-03 | 171 | 52 | 3 | 341f9f79c1ed654ab347e25dc4936f89ffdf9617 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.04e-03 | 171 | 52 | 3 | ce290930385cac35dbd21a5e91cf0f93cf3e99f8 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-03 | 172 | 52 | 3 | de4961f4037c439d3e0ec706a257b0ec17f4d5be | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 172 | 52 | 3 | 17a486c5d0430abb133eab9f087e2ef8b60f7d25 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 172 | 52 | 3 | 3acf35b774ebc0f9e96299d0bd3e9d03bbf6b90c | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-03 | 172 | 52 | 3 | 6503e85182eb6e8a40a890e393e9ac5c5350e322 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.06e-03 | 172 | 52 | 3 | 9497948bbe53fb88c6ff6b347f743d456da587e5 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 172 | 52 | 3 | b3c53fd7e50f36de6a8585ae21d04e17932f262c | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 172 | 52 | 3 | 4d04df9776394ea156ed5822f92ae74fdefbaa3d | |
| Disease | parental longevity | 7.92e-06 | 494 | 44 | 7 | EFO_0007796 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.83e-05 | 152 | 44 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 1.15e-04 | 63 | 44 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 1.65e-04 | 71 | 44 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | mean reticulocyte volume | 1.66e-04 | 799 | 44 | 7 | EFO_0010701 | |
| Disease | bipolar disorder | 2.05e-04 | 577 | 44 | 6 | MONDO_0004985 | |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 2.25e-04 | 15 | 44 | 2 | EFO_0004791, HP_0002140 | |
| Disease | Ischemic stroke, plasminogen activator inhibitor 1 measurement | 2.57e-04 | 16 | 44 | 2 | EFO_0004792, HP_0002140 | |
| Disease | factor XI measurement, Ischemic stroke | 2.91e-04 | 17 | 44 | 2 | EFO_0004694, HP_0002140 | |
| Disease | tuberculosis | 3.01e-04 | 216 | 44 | 4 | MONDO_0018076 | |
| Disease | factor VIII measurement, Ischemic stroke | 3.66e-04 | 19 | 44 | 2 | EFO_0004630, HP_0002140 | |
| Disease | coronary artery disease, factor VII measurement | 6.13e-04 | 111 | 44 | 3 | EFO_0001645, EFO_0004619 | |
| Disease | large artery stroke | 6.46e-04 | 113 | 44 | 3 | EFO_0005524 | |
| Disease | Antihypertensive use measurement | 6.51e-04 | 265 | 44 | 4 | EFO_0009927 | |
| Disease | factor XI measurement, coronary artery disease | 6.80e-04 | 115 | 44 | 3 | EFO_0001645, EFO_0004694 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 7.33e-04 | 118 | 44 | 3 | EFO_0001645, EFO_0004629 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 8.01e-04 | 28 | 44 | 2 | DOID:1094 (implicated_via_orthology) | |
| Disease | Ischemic stroke, factor VII measurement | 8.60e-04 | 29 | 44 | 2 | EFO_0004619, HP_0002140 | |
| Disease | longevity, healthspan, parental longevity | 8.60e-04 | 29 | 44 | 2 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | angina pectoris | 8.66e-04 | 125 | 44 | 3 | EFO_0003913 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 9.06e-04 | 127 | 44 | 3 | EFO_0008595, EFO_0020947 | |
| Disease | diastolic blood pressure, unipolar depression | 9.21e-04 | 30 | 44 | 2 | EFO_0003761, EFO_0006336 | |
| Disease | Ischemic stroke, von Willebrand factor measurement | 9.21e-04 | 30 | 44 | 2 | EFO_0004629, HP_0002140 | |
| Disease | self rated health | 9.83e-04 | 31 | 44 | 2 | EFO_0004778 | |
| Disease | Global developmental delay | 1.04e-03 | 133 | 44 | 3 | C0557874 | |
| Disease | stroke | 1.30e-03 | 144 | 44 | 3 | EFO_0000712 | |
| Disease | lactate measurement | 1.55e-03 | 39 | 44 | 2 | EFO_0007745 | |
| Disease | major depressive disorder | 1.61e-03 | 155 | 44 | 3 | MONDO_0002009 | |
| Disease | spleen volume | 1.89e-03 | 43 | 44 | 2 | EFO_0600047 | |
| Disease | mouth morphology measurement | 2.54e-03 | 50 | 44 | 2 | EFO_0007955 | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 2.65e-03 | 51 | 44 | 2 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | peripheral arterial disease | 2.96e-03 | 54 | 44 | 2 | EFO_0004265 | |
| Disease | Peripheral Nervous System Diseases | 2.96e-03 | 54 | 44 | 2 | C4721453 | |
| Disease | diastolic blood pressure, alcohol consumption measurement | 2.96e-03 | 54 | 44 | 2 | EFO_0006336, EFO_0007878 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQHPRHSRPRKTAAS | 186 | Q96MC4 | |
| RHPVPRQRKCRRQHS | 116 | Q5T6M2 | |
| RRLFHPHPHRQRKES | 541 | Q9NZJ5 | |
| LSVRCRHNPNHQLPR | 366 | O60477 | |
| RRGAQLRRPRHSHPT | 81 | Q8N726 | |
| SRTQSAHQSRRPHLP | 581 | Q8IYM0 | |
| EPRRHRAHRHQDPSK | 931 | Q00975 | |
| RRRPLPRIHAHDQQL | 741 | Q7Z5Q5 | |
| QLVRPPIRSHHSNTR | 251 | Q8WWK9 | |
| PPRRRRHRNRAPSSH | 11 | P61578 | |
| RLRPHVSPRHSFNNL | 211 | Q01201 | |
| KRPHLRRSASNGHVP | 121 | Q6IPM2 | |
| VPDHPHLSRRRRNKR | 141 | Q9Y5R2 | |
| RIHSPSERKHERQPR | 346 | Q9Y5R2 | |
| KARRSPGRRRHPHSS | 141 | Q96PY0 | |
| PRMSPKAQRHPRNHR | 621 | Q99700 | |
| KAQRHPRNHRVSAGR | 626 | Q99700 | |
| QQRKARHRSHGPLLP | 1021 | Q9UPA5 | |
| RRTSKAQRVHPQPSH | 66 | Q8NBC4 | |
| RKRPSSARRHHLGPT | 406 | Q9UIS9 | |
| RNPNHRPRAADLLKH | 371 | P41279 | |
| RSKAKRSRHHQNPRA | 836 | O15534 | |
| ESKQQRKARHRPHGP | 1751 | Q9Y6V0 | |
| DHPPKDLRIRRQHSS | 1656 | Q8IVL0 | |
| PPKRRPNHRRFLHNQ | 41 | A0A1B0GUS0 | |
| AHASPKLRHPRINSR | 371 | P78334 | |
| RRKRFQRHQPTPGAH | 196 | Q12950 | |
| HNNSKHGRRARRLDP | 236 | Q9BQW3 | |
| SLSPHRPRHSRLQRE | 76 | P09958 | |
| RHTARSKAARRPSHP | 556 | Q8TBE0 | |
| EHPKTRRRSSLHSQP | 481 | Q5JRC9 | |
| QAPRRRSVTPAAKRH | 181 | Q8TD94 | |
| HHRPRQSLRRRPQSS | 71 | Q5TCM9 | |
| GTHKLPRHRPLNRTQ | 436 | Q9UKV0 | |
| DKRRHETHRRPSPQR | 701 | Q8N0W4 | |
| TAHSARKQPRRPHFL | 1001 | A8K8P3 | |
| NRQPTLHRPSIQAHR | 551 | O95602 | |
| APAHSEKPRRRQHAA | 501 | Q9NUQ6 | |
| SRHRAKHQTNPRSRP | 256 | Q96D09 | |
| RDPAHPALRLLRQHR | 266 | Q6IA17 | |
| SPPQVSRHKSHYRNR | 421 | Q7L7X3 | |
| PNRSRRHSPHQALRK | 216 | P13725 | |
| RRKQLRAHLRRCHPP | 156 | Q9BWE0 | |
| SAPPQRNRRKSVHRV | 216 | Q9Y242 | |
| RSLSPRHNTPKGNRR | 161 | Q5TC79 | |
| QRRPRHRIQSKHRPL | 116 | Q6VEQ5 | |
| QRRPRHRIQSKHRPL | 116 | A8K0Z3 | |
| KPNLTRHRRNHTGER | 486 | Q96BV0 | |
| QRRPRHRIQSKHRPL | 116 | C4AMC7 | |
| QKSQPRRRHASAPSH | 331 | O60343 | |
| PHLDARPRNSHTNHR | 6 | Q9P2E3 | |
| RSSPPRAAGHRSHKR | 236 | Q8N9G6 | |
| RLHQKRRHPTAAPAR | 1151 | P52746 | |
| PRHRIQSKHRPLDER | 101 | Q9NQA3 | |
| QVHHSRRARGRRPPQ | 666 | Q9P2Y4 | |
| RLRPNKFRHRHKQTP | 1156 | Q9NR99 |